Consumers Health Forum worried on biosimilars

The Consumers Health Forum has expressed its concerns about the issue of substitution of biological medicines with biosimilars, at a meeting called by the Pharmaceutical Benefits Advisory Committee. CEO of the Forum, Leanne Wells, says that at the meeting there was “a consistency in the concern and opposition from clinical and consumer groups concerning the